CD34+ HSC LNP Kits
Source: Cytiva
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
The CD34+ HSC LNP kit is an LNP reagent mix optimized for the delivery of mRNA or Cas9 mRNA/sgRNA into CD34+ HSCs. This reagent enables researchers to establish a clinically relevant and scalable method at the discovery and preclinical scale for ex vivo gene delivery and editing.
CD34+ HSC LNP kit offers the following benefits:
- Optimized LNP formulation: Deliver RNA with high transfection efficiency by using an optimized proprietary LNP formulation*
- High knockout efficiency: Achieve dose-dependent high efficiency gene knockdown and protein expression.
- High cell yield and differentiation potential: Maintain high cell viability, yield, and differentiation potential post-editing.
- Scale from discovery to preclinical: Scale up your ex vivo cell therapy research from discovery to preclinical using the NanoAssemblr™ platform.
- Validated workflow: Optimized and validated with the CD34+ HSC cell manufacturing workflow.
*LNP composition in this research-use-only kit include ionizable lipid excipients that can be licensed for future clinical evaluation.
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more